Indian Pacing Electrophysiol. J.
Indian Pacing Electrophysiol. J. 2009;
Atrial Rate And Rhythm Abnormalities In A Patient With Hyperkalemia
Download PDF 284 KBJonathan Rosman MD1, Prashan Thiagarajah MD1, Paul Schweitzer MD1, Maurice Rachko MD, Sam Hanon MD1
1Dept. of Cardiology, Beth Israel Medical Center. 16th street and 1st avenue. New York, New York 10003.
Key Words: Hyperkalemia; Atrial flutter; Conduction velocity; Membrane potential; Action potentialAddress for correspondence: Jonathan Rosman, MD, Beth Israel Medical Center, 1st Ave. at 16th Street, Baird Hall, 5th Floor, NY, NY 10003. E-mail: jrosman/at/chpnet.org
A 67 year old man presented with a serum potassium of 7.7 mEq/L and slow atrial flutter with variable A-V block and peaked T waves. Initial treatment for hyperkalemia was followed by an increase in the atrial flutter rate to 300 beats per minute. After hemodialysis the rhythm converted to sinus.
A 67 year old man with hypertension and chronic kidney disease on hemodialysis presented to the emergency department with a 2 day history of diarrhea and fatigue. He missed his last dialysis appointment because of his presenting symptoms. Physical exam revealed a blood pressure of 164/87 and irregularly irregular heart rate of 45 beats per minute (bpm). His ECG (Figure 1) showed slow atrial flutter (atrial rate ~160 bpm) with variable A-V block and peaked T waves. The patient had no known history of atrial arrhythmias and his ECG a week prior revealed normal sinus rhythm. Serum chemistry was significant for potassium of 7.7 mEq/L. Echocardiography was significant for a left atrial diameter of 4.2 cm and a right atrial diameter of 4.7 cm.
Figure 1. Admission ECG showing slow atrial flutter at an atrial cycle length of 400ms (atrial rate of 150bpm)
Initial treatment for his hyperkalemia included calcium gluconate, insulin and sodium polystyrene sulfonate (Kayexalate). Following this treatment, the atrial rate gradually increased to 214 bpm (Figure 2). The patient was hemodialyzed for definitive treatment of hyperkalemia. Thirty minutes after initiation of hemodialysis, he converted to sinus rhythm (Figure 3).
Figure 2. ECG following insulin and kayexelate showing a faster atrial flutter at an atrial cycle length of 280ms (atrial rate of 214 bpm)
Figure 3. Telemetry strip 30 minutes after initiation of hemodialysis showing an atrial cycle length of 200ms (atrial rate of 300bpm) converting to normal sinus rhythm.
Hyperkalemia produces a spectrum of ECG abnormalities and arrhythmias as a result of a range of effects on myocyte cellular electrophysiology . Hyperkalemia reduces resting membrane potential (less negative), bringing it closer to threshold. Consequently, moderate hyperkalemia (6.0 -6.5 mEq/L) leads to a small increase in conduction velocity. As potassium levels continue to increase, the rate of rise of phase 0 of the action potential is reduced. This produces an overall slowing of intraatrial and intraventricular conduction [2-4].
The ECG series in our patient allowed observation of the rhythm abnormalities with different concentrations of serum potassium. The patient presented with an atrial flutter rate of 160 bpm when his serum potassium was 7.7 mEq/L, consistent with conduction slowing at potassium levels above 6.5mEq/L. As his serum potassium level decreased his atrial rate increased to 300 bpm, consistent with relatively faster conduction at lower serum potassium levels. In addition, the patient had no history of atrial arrhythmias and his atrial flutter resolved with normalization of his serum potassium. While ventricular arrhythmias and atrial fibrillation are occasionally seen with hyperkalemia, atrial flutter is rare [4,5].
1. Fisch C. Relation of electrolyte disturbances to cardiac arrhythmias. Circulation. 1973; 47: 408-19.
2. Nygren A. Giles WR. Mathematical simulation of slowing of cardiac conduction velocity by elevated extracellular K+ in a human atrial strand. Ann Biomed Eng. 2000; 28 :951-7.
3. Whalley DW, Wendt DJ, Starmer CF, Rudy Y, Grant AO. Voltage-independent effects of extracellular K+ on the Na+ current and phase 0 of the action potential in isolated cardiac myocytes. Circ Res. 1994; 75: 491-502.
4. Parham WA, Mehdirad AA, Biermann KM, Fredman CS. Hyperkalemia revisited. Tex Heart Inst J. 2006; 33: 40-7.
5. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis. 2005; 46: 897-902.